Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Acadia Healthcare Company Inc(ACHC)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for ACHC
10/28/2026: ACHC (3-star) is a REGULAR-BUY. BUY for 11 days. Simulated Profits (-6.82%). Updated daily EoD!
Acadia Healthcare is a leading provider of behavioral healthcare services, focusing on inpatient and residential treatment across the United States. The company has a strong growth track record, driven by strategic facility acquisitions and, more recently, partnerships with acute-care health systems. Its primary opportunity lies in the rising demand for mental health services, though success remains tied to regulatory stability, labor market conditions, and reimbursement rates. Investors should be aware of operational risks, including high staffing dependencies and the potential for increased competition from larger hospital networks. This stock is generally best suited for growth-oriented investors who can tolerate the sector's inherent regulatory and price volatility.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | The company’s focus on the expanding behavioral health sector provides consistent top-line growth opportunities. |
| Momentum investor | Mixed fit | This is a conditional fit depending on positive price trends and execution metrics. |
| Value investor | Mixed fit | Valuation is often tied to growth projections rather than immediate cash yield. |
| Dividend investor | Weak fit | The company does not pay a dividend, making it unsuitable for income-focused portfolios. |
| Low-risk investor | Weak fit | The stock carries regulatory and operational risks typical of the healthcare sector, leading to volatility. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Medium / high | Healthcare stocks often react sharply to regulatory and reimbursement news. |
| Valuation risk | Medium | Growth expectations are already priced in, leaving little margin for earnings misses. |
| Competition risk (Hospital systems) | Medium / high | Large systems are expanding their own behavioral health services, increasing rivalry. |
| Business quality | Medium / high | The company has a solid, scalable business model but operates in a highly complex and sensitive industry. |
| Dividend income | Low / none | Investors should not expect income as capital is reinvested. |
| Execution risk | Medium | Success relies heavily on the ability to staff facilities and secure regulatory approvals. |
Price Behavior
Strong Uptrend
The stock has maintained a strong upward price trend across the last three quarters.
Choppy
The stock has experienced frequent reversals and pronounced short-term price swings.
Analysis of Past Performance
Type Stock | Historic Profit 3.7% | Avg. Invested days 30 | Today’s Advisory Regular Buy |
Upturn Advisory Rating  | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/28/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 2.78B USD | Price to earnings Ratio - | 1Y Target Price 33.79 |
Price to earnings Ratio - | 1Y Target Price 33.79 | ||
Volume (30-day avg) 1.6M shares | Beta 0.62 | 52 Weeks Range 11.43 - 35.83 | Updated Date 10/27/2026 |
52 Weeks Range 11.43 - 35.83 | Updated Date 10/27/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -12.42 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Inpatient Services | Revenue from inpatient psychiatric and residential treatment facilities. | This is the primary engine of the company, charging for acute hospital stays. |
| Outpatient Services | Revenue from counseling, medication-assisted treatment, and day programs. | These services provide recurring revenue and support patient transitions. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date 2026-11-04 | When After Market | Estimate 0.46 | Actual - |
Profitability
Profit Margin -33.44% | Operating Margin (TTM) 10.14% |
Management Effectiveness
Return on Assets (TTM) 3.57% | Return on Equity (TTM) -41.45% |
Valuation
Trailing PE - | Forward PE 16.75 | Enterprise Value 5.31B | Price to Sales(TTM) 0.83 |
Enterprise Value 5.31B | Price to Sales(TTM) 0.83 | ||
Enterprise Value to Revenue 1.58 | Enterprise Value to EBITDA 9.47 | Shares Outstanding 93.10M | Shares Floating 91.53M |
Shares Outstanding 93.10M | Shares Floating 91.53M | ||
Percent Insiders 1.54 | Percent Institutions 148.04 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.